Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

262 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pitavastatin-incorporated nanoparticle-eluting stents attenuate in-stent stenosis without delayed endothelial healing effects in a porcine coronary artery model.
Tsukie N, Nakano K, Matoba T, Masuda S, Iwata E, Miyagawa M, Zhao G, Meng W, Kishimoto J, Sunagawa K, Egashira K. Tsukie N, et al. Among authors: kishimoto j. J Atheroscler Thromb. 2013;20(1):32-45. doi: 10.5551/jat.13862. Epub 2012 Sep 13. J Atheroscler Thromb. 2013. PMID: 22986515 Free article.
Nanoparticle-mediated delivery of pitavastatin into lungs ameliorates the development and induces regression of monocrotaline-induced pulmonary artery hypertension.
Chen L, Nakano K, Kimura S, Matoba T, Iwata E, Miyagawa M, Tsujimoto H, Nagaoka K, Kishimoto J, Sunagawa K, Egashira K. Chen L, et al. Among authors: kishimoto j. Hypertension. 2011 Feb;57(2):343-50. doi: 10.1161/HYPERTENSIONAHA.110.157032. Epub 2011 Jan 10. Hypertension. 2011. PMID: 21220711
Can intensive lipid-lowering therapy improve the carotid intima-media thickness in Japanese subjects under primary prevention for cardiovascular disease?: The JART and JART extension subanalysis.
Daida H, Nohara R, Hata M, Kaku K, Kawamori R, Kishimoto J, Kurabayashi M, Masuda I, Sakuma I, Yamazaki T, Yokoi H, Yoshida M; Justification for Atherosclerosis Regression Treatment (JART) Investigators. Daida H, et al. Among authors: kishimoto j. J Atheroscler Thromb. 2014;21(7):739-54. doi: 10.5551/jat.19109. Epub 2014 Jun 20. J Atheroscler Thromb. 2014. PMID: 24953046 Free article. Clinical Trial.
Ezetimibe in Combination With Statins Ameliorates Endothelial Dysfunction in Coronary Arteries After Stenting: The CuVIC Trial (Effect of Cholesterol Absorption Inhibitor Usage on Target Vessel Dysfunction After Coronary Stenting), a Multicenter Randomized Controlled Trial.
Takase S, Matoba T, Nakashiro S, Mukai Y, Inoue S, Oi K, Higo T, Katsuki S, Takemoto M, Suematsu N, Eshima K, Miyata K, Yamamoto M, Usui M, Sadamatsu K, Satoh S, Kadokami T, Hironaga K, Ichi I, Todaka K, Kishimoto J, Egashira K, Sunagawa K. Takase S, et al. Among authors: kishimoto j. Arterioscler Thromb Vasc Biol. 2017 Feb;37(2):350-358. doi: 10.1161/ATVBAHA.116.308388. Epub 2016 Dec 8. Arterioscler Thromb Vasc Biol. 2017. PMID: 27932353 Clinical Trial.
Safety, Tolerability, and Pharmacokinetics of NK-104-NP.
Nakano K, Matoba T, Koga JI, Kashihara Y, Fukae M, Ieiri I, Shiramoto M, Irie S, Kishimoto J, Todaka K, Egashira K. Nakano K, et al. Among authors: kishimoto j. Int Heart J. 2018 Sep 26;59(5):1015-1025. doi: 10.1536/ihj.17-555. Epub 2018 Aug 29. Int Heart J. 2018. PMID: 30158384 Free article. Clinical Trial.
Association between Serum Oxysterols and Coronary Plaque Regression during Lipid-Lowering Therapy with Statin and Ezetimibe: Insights from the CuVIC Trial.
Nakano Y, Yamamoto M, Matoba T, Katsuki S, Nakashiro S, Takase S, Akiyama Y, Nagata T, Mukai Y, Inoue S, Oi K, Higo T, Takemoto M, Suematsu N, Eshima K, Miyata K, Usui M, Sadamatsu K, Kadokami T, Hironaga K, Ichi I, Todaka K, Kishimoto J, Tsutsui H. Nakano Y, et al. Among authors: kishimoto j. J Atheroscler Thromb. 2023 Aug 1;30(8):907-918. doi: 10.5551/jat.63507. Epub 2022 Dec 1. J Atheroscler Thromb. 2023. PMID: 36450458 Free PMC article. Clinical Trial.
Association of Serum Oxysterols with Cholesterol Metabolism Markers and Clinical Factors in Patients with Coronary Artery Disease: A Covariance Structure Analysis.
Akiyama Y, Katsuki S, Matoba T, Nakano Y, Takase S, Nakashiro S, Yamamoto M, Mukai Y, Inoue S, Oi K, Higo T, Takemoto M, Suematsu N, Eshima K, Miyata K, Usui M, Sadamatsu K, Kadokami T, Hironaga K, Ichi I, Todaka K, Kishimoto J, Tsutsui H. Akiyama Y, et al. Among authors: kishimoto j. Nutrients. 2023 Jun 30;15(13):2997. doi: 10.3390/nu15132997. Nutrients. 2023. PMID: 37447327 Free PMC article.
Can intensive lipid-lowering therapy with statins ameliorate atherosclerosis in Japanese patients? Rationale and design of the JART study.
Kurabayashi M, Sakuma I, Kawamori R, Daida H, Yamazaki T, Yoshida M, Hata M, Masuda I, Kaku K, Yokoi H, Kishimoto J, Nohara R. Kurabayashi M, et al. Among authors: kishimoto j. J Atheroscler Thromb. 2010 Apr 30;17(4):416-22. doi: 10.5551/jat.2899. Epub 2010 Mar 9. J Atheroscler Thromb. 2010. PMID: 20215710 Free article. Clinical Trial.
262 results